{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:25:13Z","timestamp":1793845513120,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018-01760"],"award-info":[{"award-number":["2018-01760"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.socscimed.2026.119909","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:09:23Z","timestamp":1791040163000},"page":"119909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alternative visions: The strategic partial medicalization of ibogaine treatment"],"prefix":"10.1016","volume":"410","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7657-5730","authenticated-orcid":false,"given":"Jakob","family":"Lundgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-2452","authenticated-orcid":false,"given":"Johan","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.socscimed.2026.119909_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0038038510369368","article-title":"Pharmaceuticalization of society in context: theoretical, empirical and health dimensions","volume":"44","author":"Abraham","year":"2010","journal-title":"Sociology"},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","article-title":"Fatalities temporally associated with the ingestion of ibogaine","volume":"57","author":"Alper","year":"2012","journal-title":"J. Forensic Sci."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/soc4.12959","article-title":"The frontiers of new psychedelic therapies: a survey of sociological themes and issues","volume":"16","author":"Andrews","year":"2022","journal-title":"Sociol. Compass"},{"issue":"4","key":"10.1016\/j.socscimed.2026.119909_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5172\/hesr.451.17.4.331","article-title":"Taking stock of integrative medicine: broadening biomedicine or co-option of complementary and alternative medicine?","volume":"17","author":"Baer","year":"2008","journal-title":"Health Sociol. Rev."},{"key":"10.1016\/j.socscimed.2026.119909_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102857","article-title":"Ibogaine therapy for addiction: consumer views from online fora","volume":"83","author":"Barber","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"5","key":"10.1016\/j.socscimed.2026.119909_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.socscimed.2012.04.002","article-title":"Medicalization and pharmaceuticalization at the intersections: looking backward, sideways and forward","volume":"75","author":"Bell","year":"2012","journal-title":"Soc. Sci. Med."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/02791072.2019.1598603","article-title":"Ibogaine and subjective experience: transformative states and psychopharmacotherapy in the treatment of opioid use disorder","volume":"51","author":"Brown","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"5","key":"10.1016\/j.socscimed.2026.119909_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/1467-9566.12538","article-title":"The concept of medicalisation reassessed","volume":"39","author":"Busfield","year":"2017","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2026.119909_bib12","first-page":"1","article-title":"Magnesium\u2013ibogaine therapy in veterans with traumatic brain injuries","author":"Cherian","year":"2024","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:PHEN.0000040824.89221.1a","article-title":"Interactional expertise as a third kind of knowledge","volume":"3","author":"Collins","year":"2004","journal-title":"Phenomenol. Cognitive Sci."},{"key":"10.1016\/j.socscimed.2026.119909_bib14","series-title":"The Medicalization of Society: on the Transformation of Human Conditions into Treatable Disorders","author":"Conrad","year":"2007"},{"issue":"10","key":"10.1016\/j.socscimed.2026.119909_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/0002764212454422","article-title":"Tactics of legitimation in the psychedelic sciences: lessons for feminist sociology of knowledge","volume":"56","author":"Corbin","year":"2012","journal-title":"Am. Behav. Sci."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/1467-9566.12820","article-title":"Medicalisation, pharmaceuticalisation, or both? Exploring the medical management of sleeplessness as insomnia","volume":"41","author":"Coveney","year":"2019","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2026.119909_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.1256396","article-title":"Case report: ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion","volume":"4","author":"Dickinson","year":"2023","journal-title":"Frontiers in Pain Research"},{"key":"10.1016\/j.socscimed.2026.119909_bib18","article-title":"Clinical guidelines for ibogaine-assisted detoxification","author":"Dickinson","year":"2015","journal-title":"IBOGAINE SAFETY GUIDELINES"},{"key":"10.1016\/j.socscimed.2026.119909_bib17","author":"Dickinson"},{"key":"10.1016\/j.socscimed.2026.119909_bib22","article-title":"The future of iboga: perspectives from central Africa","author":"Faura","year":"2020","journal-title":"International Center for Ethnobotanical Education, Research and Service (ICEERS)"},{"key":"10.1016\/j.socscimed.2026.119909_bib21","article-title":"Visions on iboga\/ine: from the international community","author":"Faura","year":"2019","journal-title":"International Center for Ethnobotanical Education, Research and Service (ICEERS)"},{"key":"10.1016\/j.socscimed.2026.119909_bib24","article-title":"What if psychedelics' hallucinations are just a side effect?","author":"Friedman","year":"2023","journal-title":"Atlantic"},{"issue":"6","key":"10.1016\/j.socscimed.2026.119909_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/soc4.12182","article-title":"The sociology of traditional, complementary and alternative medicine","volume":"8","author":"Gale","year":"2014","journal-title":"Sociol. Compass"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb05211.x","article-title":"18-Methoxycoronaridine (18-MC) and ibogaine: Comparison of antiaddictive efficacy, toxicity, and mechanisms of action","volume":"914","author":"Glick","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.socscimed.2026.119909_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/02791072.2017.1290855","article-title":"Examination of the phenomenology of the ibogaine treatment experience: role of altered states of consciousness and psychedelic experiences","volume":"49","author":"Heink","year":"2017","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.socscimed.2026.119909_bib30","series-title":"The Public Shaping of Medical Research: Patient Associations, Health Movements, and Biomedicine","first-page":"151","article-title":"Beyond scientific consensus: scientific counterpublics, countervailing industries, and competing research agendas","author":"Hess","year":"2014"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119909_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41557-024-01714-7","article-title":"Efficient and modular synthesis of ibogaine and related alkaloids","volume":"17","author":"Iyer","year":"2025","journal-title":"Nat. Chem."},{"issue":"6","key":"10.1016\/j.socscimed.2026.119909_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/0306312707076600","article-title":"Alternative medicine's encounter with laboratory science: the scientific construction of Korean medicine in a global age","volume":"37","author":"Kim","year":"2007","journal-title":"Soc. Stud. Sci."},{"issue":"4","key":"10.1016\/j.socscimed.2026.119909_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/03063127221092180","article-title":"Thinking differently with Chinese medicine: \u2018explanations\u2019 and case studies for a postcolonial STS","volume":"52","author":"Lin","year":"2022","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.socscimed.2026.119909_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826084.2024.2403109","article-title":"Ibogaine: revisiting an ancient alkaloid for modern opioid dependence","author":"Moore","year":"2025","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1363459312447252","article-title":"How \u2018alternative\u2019 is CAM? Rethinking conventional dichotomies between biomedicine and complementary\/alternative medicine","volume":"17","author":"Ning","year":"2013","journal-title":"Health"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44184-026-00185-7","article-title":"Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders","volume":"5","author":"Olash","year":"2026","journal-title":"Npj Mental Health Research"},{"issue":"5","key":"10.1016\/j.socscimed.2026.119909_bib39","first-page":"518","article-title":"Complementary and alternative medicine: an overview","volume":"82","author":"Pal","year":"2002","journal-title":"Curr. Sci."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1467-9566.2012.01476.x","article-title":"The medicalisation of revolt: a sociological analysis of medical cannabis users","volume":"35","author":"Pedersen","year":"2013","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2026.119909_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.s794","article-title":"Trump's psychedelic executive order: president expands access to psychoactive drugs","volume":"393","author":"Reddick","year":"2026","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/13648470.2018.1544605","article-title":"Searching for a \u2018new magical world\u2019: the contradictions of CAM and new age therapies in the west","volume":"27","author":"Ricc\u00f2","year":"2020","journal-title":"Anthropol. Med."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119909_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1556\/2054.01.2017.007","article-title":"A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment","volume":"1","author":"Schenberg","year":"2017","journal-title":"Journal of Psychedelic Studies"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119909_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/00031224221081379","article-title":"Operationalizing legitimacy","volume":"87","author":"Schoon","year":"2022","journal-title":"Am. Sociol. Rev."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib46","first-page":"10","article-title":"Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States","volume":"10","author":"Schwarz-Plaschg","year":"2022","journal-title":"Eur. J. For. Res."},{"issue":"4","key":"10.1016\/j.socscimed.2026.119909_bib6","first-page":"385","article-title":"The psychedelic renaissance: a case of outlaw user innovation in the pharmaceutical industry","volume":"38","author":"S\u00f6derberg","year":"2022","journal-title":"Prometheus"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib5","doi-asserted-by":"crossref","DOI":"10.1057\/s41285-025-00220-1","article-title":"Risk management in a global market of alternative addiction care: a case study of the ibogaine medical subculture","volume":"23","author":"S\u00f6derberg","year":"2025","journal-title":"Soc. Theor. Health"},{"issue":"8","key":"10.1016\/j.socscimed.2026.119909_bib47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/1467-9566.13513","article-title":"Medicalising the menace? The symbiotic convergence of medicine and law enforcement in the medicalisation of marijuana in Minnesota","volume":"44","author":"Steel","year":"2022","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2026.119909_bib48","series-title":"Abductive Analysis: Theorizing Qualitative Research","author":"Tavory","year":"2014"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119909_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0735275112457914","article-title":"Theory construction in qualitative research: from grounded theory to abductive analysis","volume":"30","author":"Timmermans","year":"2012","journal-title":"Sociol. Theor."},{"issue":"5720","key":"10.1016\/j.socscimed.2026.119909_bib50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1126\/science.308.5720.345","article-title":"Ibogaine therapy: a \u201cVast, Uncontrolled Experiment.\u201d","volume":"308","author":"Vastag","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.socscimed.2026.119909_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0306312709104075","article-title":"Active compounds and atoms of society: plants, bodies, minds and cultures in the work of Kenyan ethnobotanical knowledge","volume":"39","author":"Wenzel Geissler","year":"2009","journal-title":"Soc. Stud. Sci."},{"issue":"5","key":"10.1016\/j.socscimed.2026.119909_bib54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/1467-9566.12576","article-title":"The concept of medicalisation reassessed: a response to joan busfield","volume":"39","author":"Williams","year":"2017","journal-title":"Sociol. Health Illness"},{"issue":"5","key":"10.1016\/j.socscimed.2026.119909_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1467-9566.2011.01320.x","article-title":"The pharmaceuticalisation of society? A framework for analysis","volume":"33","author":"Williams","year":"2011","journal-title":"Sociol. Health Illness"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119909_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/fhu2.70004","article-title":"The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance","volume":"3","author":"Yoo","year":"2024","journal-title":"Future Humanit."}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953626009871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953626009871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:29:37Z","timestamp":1793842177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953626009871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0277953626009871"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2026.119909","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative visions: The strategic partial medicalization of ibogaine treatment","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2026.119909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"119909"}}